Related Experiment Video
Updated: May 24, 2026

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
Published on: April 16, 2013
An auto-perfusing umbilical cord blood collection instrument
1Department of Electrical & Computer Engineering, National University of Singapore, Singapore. eletankk@nus.edu.sg
This study details an automated instrument for umbilical cord blood (UCB) collection, enhancing hematopoietic stem cell (HSC) yield. The novel device improves upon manual syringe methods for greater clinical utility.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cell Biology
Background:
- Umbilical cord blood (UCB) is a valuable source of hematopoietic stem cells (HSCs) for clinical applications.
- Current manual UCB collection methods using syringes are limited in volume and cell yield.
- There is a need for improved, automated methods for UCB collection to maximize cellular recovery.
Purpose of the Study:
- To present the development of an automated instrument for UCB collection.
- To overcome the limitations of current manual collection techniques.
- To enhance the yield and quality of UCB for clinical use.
Main Methods:
- Development of a multi-component automated UCB collection instrument.
- Incorporation of a placenta handling system simulating uterine compression via air pressure.
- Integration of an auto-medium injector for automated perfusion.
- Implementation of a time window widening system using vibrations to maintain cord temperature.
- A central control platform to manage and automate all subsystems.
Main Results:
- The developed instrument comprises four integrated subsystems for automated UCB collection.
- The placenta handling system effectively emulates uterine compression.
- The auto-medium injector and time window widening system optimize perfusion and cell viability.
- The control platform successfully integrates and automates the collection process.
Conclusions:
- The automated UCB collection instrument offers improved performance over manual methods.
- This technology has the potential to increase the availability of HSCs for clinical therapies.
- Further research and clinical validation are warranted to establish the full potential of this automated system.
More Related Videos
13:46Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
Published on: April 13, 2012
10:42Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
Published on: April 11, 2019